Gilead Sciences
Corprate Bias Ratings
Risk Level:
Summary:
Gilead Sciences vets vendors according to LGBTQ policies but has not publicly terminated business relationships based on views or beliefs. It does not discriminate against religious organizations in its charitable giving guidelines, but does not provide viewpoint protections for its employees. Gilead Sciences has advocated for the Equality Act and partners with the Human Rights Campaign (HRC). Gilead also covers abortion-related travel costs for employees and the cost of "medically necessary transition-related care" for its employees and their children. The company pledged $10 million to BLM and related causes and corporately denounced state legislative efforts to revise their own electoral processes. However, Gilead has not used its political contributions to advance ideological causes. For these reasons, Gilead Sciences receives a Medium Risk rating.
Has denied service to customers, suppliers, or vendors due to their political views or religious beliefs OR corporately boycotts, divests, or sanctions regions, people groups, or industries.
Gilead Sciences has not publicly fired customers, suppliers, or vendors based on political views or religious beliefs. The company received a score of 100 on the Human Rights Campaign’s (HRC) Corporate Equality Index. Among other requirements, this means the company has a written policy pledging to vet vendors for LGBTQ policies (1)(2).
Charitable giving (including employee matching programs) policies or practices discriminate against charitable organizations based on views or religious beliefs.
Gilead Science only funds organizations related to medical, scientific, and patient community support (1). It does not discriminate against religious organizations in its charitable giving.
Employment policies fail to protect against discrimination based on political affiliation/views and/or religion.
Gilead Sciences does not provide viewpoint protections for its employees (1).
Uses corporate reputation to support ideological causes and/or organizations hostile to freedom of expression.
Gilead has advocated for the Equality Act (1). The company also spoke out against what it called “voter suppression” in various conservative states as those states amended their election laws after the pandemic (2). The letter called for boycotting events in those states and divesting business when possible.
Uses corporate funds to advance ideological causes, organizations, or policies hostile to freedom of expression.
Gilead Sciences has a perfect score on the HRC’s 2022 Corporate Equality Index. This score indicates the company covers the cost of “medically necessary transition-related care” for its employees and their children (1)(2). Gilead also pays for its employees’ travel and lodging to get an abortion (3). Gilead Sciences funded the HRC (4). Gilead is a Bronze sponsor of Out and Equal and is a corporate partner of the National LGBT Chamber of Commerce (5)(6). Gilead has pledged $10 million to the Black Lives Matter movement and related causes (7)(8).
All links were last accessed and all information was updated on:
December 5, 2023
Company reports are intended for educational use only. Full Disclaimer
Voting History
| Date | ESG Category | Proponent | Summary of Resolution | Mgmt Rec | Total Vote % in Favor |
|---|---|---|---|---|---|
| 5/3/23 | Social | Adrian Dominican Sisters | Report on Impact of Extended Patent Exclusivities on Product Access | Against | 16.50% |
| 5/3/23 | Governance | John Chevedden | Special Shareholder Meeting Improvement | Against | 4.60% |
| 5/3/23 | Governance | Jing Zhao | Nominate More Candidates than there are Directors | Against | 0.70% |
| 5/4/22 | Governance | John Chevedden | Special Meetings - Reduce Ownership Req. to 10% | Against | 56.66% |
| 5/4/22 | Social | Maryknoll Sisters of St. Dominic | 3rd Party Review of Alignment of Lobbying with its Public Statements | Against | 49.88% |
| 5/4/22 | Governance | United Church Funds | Require Independent Board Chair | Against | 40.33% |
| 5/4/22 | Governance | Mercy Investment Services | Report on Board Oversight of Risks Related to Anticompetitive Practices | Against | 39.27% |
| 5/4/22 | Governance | Jing Zhao | Adopt a Policy to Include Non-Management Employee as Director Candidates | Against | 6.67% |